Sean A. McCarthy - 11 Aug 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
President and CEO, Director
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Sean A. McCarthy
Issuer symbol
CTMX
Transactions as of
11 Aug 2021
Net transactions value
+$104,447
Form type
4
Filing time
13 Aug 2021, 17:22:02 UTC
Previous filing
21 Jun 2021
Next filing
26 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Options Exercise $104,447 +92,113 +1180% $1.13 99,922 11 Aug 2021 Direct F1
holding CTMX Common Stock 93,158 11 Aug 2021 See footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Options Exercise $0 -92,113 -100% $0.000000* 0 11 Aug 2021 Common Stock 92,113 $1.13 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities held has been adjusted to reflect the transfer of 40 shares previously owned directly to Sean A. McCarthy 2018 Trust.
F2 Shares held by Sean A. McCarthy 2018 Trust, of which Reporting Person is trustee.
F3 Exercise of September 2021 expiring stock options with cash.
F4 100% of the shares subject to the option are fully vested and exercisable.